Cargando…

Vasoactive Peptide Levels after Change of Dialysis Mode

BACKGROUND/AIMS: Plasma concentrations of the N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) are increased in end-stage renal disease. Improvement in hemodynamic stability has been reported when switching from hemodialysis (HD) to on-line hemodiafiltration (ol-HDF). The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Uhlin, Fredrik, Odar-Cederlöf, Ingegerd, Theodorsson, Elvar, Fernström, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662277/
https://www.ncbi.nlm.nih.gov/pubmed/26648973
http://dx.doi.org/10.1159/000440816
_version_ 1782403136382566400
author Uhlin, Fredrik
Odar-Cederlöf, Ingegerd
Theodorsson, Elvar
Fernström, Anders
author_facet Uhlin, Fredrik
Odar-Cederlöf, Ingegerd
Theodorsson, Elvar
Fernström, Anders
author_sort Uhlin, Fredrik
collection PubMed
description BACKGROUND/AIMS: Plasma concentrations of the N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) are increased in end-stage renal disease. Improvement in hemodynamic stability has been reported when switching from hemodialysis (HD) to on-line hemodiafiltration (ol-HDF). The aim of this study was to investigate plasma concentrations of NT-proBNP, BNP and neuropeptide Y (NPY) during a 1-year follow-up, after a change from high-flux HD to postdilution ol-HDF. Additional variables were also studied, e.g. pulse wave velocity and ordinary clinical parameters. METHOD: We conducted a prospective, single-center study including 35 patients who were switched from HD to HDF. Plasma concentrations of NT-proBNP, BNP and NPY before and after dialysis were measured at baseline (i.e. HD) and at 1, 2, 4, 6 and 12 months on HDF. RESULTS: All three peptide levels decreased significantly during HD and HDF when comparing concentrations before and after dialysis. Mean absolute value (before/after) and relative decrease (%) before versus after dialysis was 13.697/9.497 ng/l (31%) for NT-proBNP, 62/40 ng/ml (35%) for BNP and 664/364 pg/l (45%) for NPY. No significant differences were observed when comparing predialysis values over time. However, postdialysis NT-proBNP concentration showed a significant decrease of 48% over time after the switch to HDF. CONCLUSION: The postdialysis plasma levels of NT-proBNP, BNP and NPY decreased significantly during both dialysis modes when compared to before dialysis. The postdialysis lowering of NT-proBNP increased further over time after the switch to ol-HDF; the predialysis levels were unchanged, suggesting no effect on its production in the ventricles of the heart.
format Online
Article
Text
id pubmed-4662277
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-46622772015-12-08 Vasoactive Peptide Levels after Change of Dialysis Mode Uhlin, Fredrik Odar-Cederlöf, Ingegerd Theodorsson, Elvar Fernström, Anders Nephron Extra Original Paper BACKGROUND/AIMS: Plasma concentrations of the N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) are increased in end-stage renal disease. Improvement in hemodynamic stability has been reported when switching from hemodialysis (HD) to on-line hemodiafiltration (ol-HDF). The aim of this study was to investigate plasma concentrations of NT-proBNP, BNP and neuropeptide Y (NPY) during a 1-year follow-up, after a change from high-flux HD to postdilution ol-HDF. Additional variables were also studied, e.g. pulse wave velocity and ordinary clinical parameters. METHOD: We conducted a prospective, single-center study including 35 patients who were switched from HD to HDF. Plasma concentrations of NT-proBNP, BNP and NPY before and after dialysis were measured at baseline (i.e. HD) and at 1, 2, 4, 6 and 12 months on HDF. RESULTS: All three peptide levels decreased significantly during HD and HDF when comparing concentrations before and after dialysis. Mean absolute value (before/after) and relative decrease (%) before versus after dialysis was 13.697/9.497 ng/l (31%) for NT-proBNP, 62/40 ng/ml (35%) for BNP and 664/364 pg/l (45%) for NPY. No significant differences were observed when comparing predialysis values over time. However, postdialysis NT-proBNP concentration showed a significant decrease of 48% over time after the switch to HDF. CONCLUSION: The postdialysis plasma levels of NT-proBNP, BNP and NPY decreased significantly during both dialysis modes when compared to before dialysis. The postdialysis lowering of NT-proBNP increased further over time after the switch to ol-HDF; the predialysis levels were unchanged, suggesting no effect on its production in the ventricles of the heart. S. Karger AG 2015-10-28 /pmc/articles/PMC4662277/ /pubmed/26648973 http://dx.doi.org/10.1159/000440816 Text en Copyright © 2015 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
spellingShingle Original Paper
Uhlin, Fredrik
Odar-Cederlöf, Ingegerd
Theodorsson, Elvar
Fernström, Anders
Vasoactive Peptide Levels after Change of Dialysis Mode
title Vasoactive Peptide Levels after Change of Dialysis Mode
title_full Vasoactive Peptide Levels after Change of Dialysis Mode
title_fullStr Vasoactive Peptide Levels after Change of Dialysis Mode
title_full_unstemmed Vasoactive Peptide Levels after Change of Dialysis Mode
title_short Vasoactive Peptide Levels after Change of Dialysis Mode
title_sort vasoactive peptide levels after change of dialysis mode
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662277/
https://www.ncbi.nlm.nih.gov/pubmed/26648973
http://dx.doi.org/10.1159/000440816
work_keys_str_mv AT uhlinfredrik vasoactivepeptidelevelsafterchangeofdialysismode
AT odarcederlofingegerd vasoactivepeptidelevelsafterchangeofdialysismode
AT theodorssonelvar vasoactivepeptidelevelsafterchangeofdialysismode
AT fernstromanders vasoactivepeptidelevelsafterchangeofdialysismode